Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study
Title:
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study
Author:
Massari, Francesco Mollica, Veronica Fiala, Ondrej De Giorgi, Ugo Kucharz, Jakub Vitale, Maria Giuseppa Molina-Cerrillo, Javier Facchini, Gaetano Seront, Emmanuel Lenci, Edoardo Bourlon, Maria T. Carrozza, Francesco Pichler, Renate Lolli, Cristian Myint, Zin W. Kanesvaran, Ravindran Torniai, Mariangela Rescigno, Pasquale Gomez de LiaƱo, Alfonso Zakopoulou, Roubini Buti, Sebastiano Porta, Camillo Grande, Enrique Santoni, Matteo